About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Price analytics
Returns
1 day
-1.5%
1 week
1.3%
1 month
1.5%
3 months
9.9%
6 months
15.2%
1 year
10.7%
3 years
80.3%
Risk
Volatility (1y ann.)
24.6%
Beta vs ASX 200
0.81
Sharpe (1y)
0.38
VaR 95% (1-day)
-2.3%
Max drawdown (1y)
-23.1%
Off 1-year high
-1.7%
Technicals
RSI(14)
69
vs 50DMA
3.1%
vs 200DMA
12.5%
Trend
Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value0.8
Trailing P/E
0
Forward P/E
0
PEG ratio
0
EV / EBITDA
0
Price / Book
0
Price / Sales
7
Growth88.4
Revenue growth (1y)
100
Revenue CAGR (3y)
73
EPS growth (1y)
88
EPS CAGR (3y)
93
Financial Health97.6
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
89
Debt / Equity
100
Quality (Profitability & Cash Flow)100.0
Return on equity
100
Return on assets
100
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income54.2
Dividend yield (%)
20
Payout ratio
82
FCF dividend cover
62
Momentum88.7
6-month return vs ASX 200
100
Price vs 200-day average
92
Price vs 50-day average
65
Position in 52-week range
91
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).